Anthralin
- 1 November 1981
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 117 (11) , 698-700
- https://doi.org/10.1001/archderm.1981.01650110020011
Abstract
• There has been recent interest in psoriasis treatment regimens with low anthralin concentrations of 0.01% and 0.05%. These regimens used salicylic acid, coal tar emollient baths, and ultraviolet energy. We were interested in evaluating the effects of different concentrations of anthralin without adjunctive therapy. We studied the effects of anthralin on epidermal cell DNA synthesis in hairless mice and found that, in concentrations between 0.1% and 0.4%, anthralin produced significant suppression. However, 0.05%, 0.025%, and 0.01% anthralin failed to inhibit DNA synthesis. Clinical studies of 0.05% and 0.1% anthralin in a water-in-oil emulsion (Eucerin) were performed on 14 patients with psoriasis. Psoriasis severity was scored before and during the period of anthralin use and showed a significant improvement in 0.1% anthralin-treated sites. No significant differences were noted between 0.05% anthralin-treated areas and those areas treated with the vehicle alone. (Arch Dermatol 1981;117:698-700)Keywords
This publication has 5 references indexed in Scilit:
- Suppression of epidermal proliferation by ultraviolet light, coal tar and anthralinBritish Journal of Dermatology, 1978
- Essential fatty acid deficient hairless mouse: the effects of topical agents on the epidermisBritish Journal of Dermatology, 1977
- Relapse rate of psoriasis worsened by adding steroids to a dithranol regime*British Journal of Dermatology, 1976
- The Effect of Anthralin and its Derivatives on Epidermal Cell KineticsJournal of Investigative Dermatology, 1975
- The Approach to PsoriasisBMJ, 1953